Analysis of the Active Pharmaceutical Ingredients Market
This study covers the active pharmaceutical ingredients (APIs) market for Singapore, Malaysia, Thailand, Philippines, Indonesia, Vietnam, Australia, and New Zealand. The study is segmented according to the customer base and the ingredient’s mode of synthesis. The study details the revenue forecasts and market trends for generic, innovative, synthetic, and biological APIs. The competitive structure is provided, along with a detailed attractiveness index for contract manufacturing of APIs in each of the countries. Furthermore, drivers and restraints influencing the market are discussed, and the revenue split by country and therapeutic areas is included. The base year is 2011, and forecasts are provided through 2018.
1. Active Pharmaceutical Ingredients